Leverage season 5 episode 15 Recap and FAQ
Episode Summary
In a high-stakes episode, a desperate doctor seeks a new drug, Trimethia, to save her patient, but the pharmaceutical company, Pallagen, refuses to release it due to low profitability. The team concocts a daring plan to infiltrate Pallagen's highly secure Highpoint Tower. Despite facing a formidable security system and life-threatening challenges, including a risky zip line maneuver and a tight escape under heavy resistance, the team successfully acquires the drug, showcasing their commitment and the extreme risks they're willing to take for the mission.
Full Episode S05E15 Recap
Frequently Asked Questions
What is the new drug mentioned in the episode?
Trimethia, a drug showing promising results in curing Stanhope's Sarcoma.
Why won't Pallagen release Trimethia?
The company considers it unprofitable due to the rarity of Stanhope's Sarcoma.
Who is desperate to obtain Trimethia and why?
A doctor, for her patient Danny Sullivan, who is running out of time.
What is significant about Highpoint Tower?
It houses a server for federal law enforcement, making it highly secure.
What security system protects Highpoint Tower?
The Steranko system, known for being almost impenetrable.
How does the team plan to infiltrate Highpoint Tower?
By entering from the top to avoid the most stringent security on the lower floors.
What complication does the team encounter during infiltration?
The communication system breaks down, indicating a possible wireless lockdown.
What risky maneuver do Parker and a team member perform?
A zip line across buildings.
What are the stakes of the mission?
Extremely high, with team members risking their lives to acquire the drug.
What happens during the team's escape?
They face heavy resistance and injuries but manage to get away with the drug.